Rémi Rabasa-Lhoret
IRCM · Institut de Recherches Cliniques de Montreal · Montreal Clinical Research Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
37
all conditions, ClinicalTrials.gov
NIH grants tied to them
1
NIH RePORTER
Trial papers
73
PubMed author-name match
Trials
Studies that name Rémi Rabasa-Lhoret as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:06 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07758647 · NO-Meal Announcement in Automated Insulin Delivery (Open-source and Commercial) SystemsInstitut de Recherches Cliniques de Montreal · not yet recruiting · Type 1 Diabetes (T1D) · principal investigator
- N/ANCT07475962 · Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · not yet recruiting · Type 1 Diabetes, Liver Steatoses, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease · principal investigator
- N/ANCT07322380 · Feasibility and Adoption of a Screening Program for T1D Relatives in CanadaInstitut de Recherches Cliniques de Montreal · not yet recruiting · Type 1 Diabetes (T1D) · principal investigator
- N/ANCT06158503 · Glycemic Control and Osteohealth in Adults Living With Type 1 DiabetesCentre hospitalier de l'Université de Montréal (CHUM) · recruiting · Type 1 Diabetes · principal investigator
- N/ANCT05626725 · Safety and Effectiveness of Automated Insulin Delivery (AID) Systems in Physically Active Adults With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- N/ANCT05304325 · Adipose Tissue Pre and Post Bariatric SurgeryInstitut de Recherches Cliniques de Montreal · unknown · Obesity · principal investigator
- N/ANCT05258292 · Glycemic Variations During the Menstrual Cycle in Women With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · recruiting · Type1diabetes · principal investigator
- N/ANCT05099939 · Identification of Dysglycemia With Continuous Glucose Monitoring to Assess Clinical Evolution in Cystic FibrosisInstitut de Recherches Cliniques de Montreal · recruiting · Cystic Fibrosis · principal investigator
- N/ANCT04876079 · Prevention of Mild-to-moderate Hypoglycemia in Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- N/ANCT04825366 · Restoration of Hypoglycemia Awareness With Home-based High Intensity Interval TrainingInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes, Hypoglycemia Unawareness · principal investigator
- N/ANCT04758858 · Carbohydrates Under Target for Type 1 Diabetes ManagementInstitut de Recherches Cliniques de Montreal · withdrawn · Type 1 Diabetes · principal investigator
- N/ANCT04496921 · Vitamin K Supplementation to Reduce Deficiencies in Adults With Cystic FibrosisInstitut de Recherches Cliniques de Montreal · withdrawn · Cystic Fibrosis · principal investigator
- N/ANCT04385862 · The Use of a Continuous Glucose Monitoring System (Dexcom G6) in Hospitalized Patients for Acute CareCentre hospitalier de l'Université de Montréal (CHUM) · withdrawn · Continuous Glucose Monitoring · principal investigator
- N/ANCT04031599 · Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose LevelsInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- N/ANCT03995498 · Individualized Carbohydrate Intake Strategy to Improve Blood Glucose ControlInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- N/ANCT03845114 · Insulin-based Strategies to Prevent Hypoglycemia During Two Types of ExerciseInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes Mellitus · principal investigator
- N/ANCT03710538 · The Effect of a Pre-meal Snack and/or Exercise on Post-prandial Glycemic Excursions in Adults With Cystic FibrosisInstitut de Recherches Cliniques de Montreal · completed · Cystic Fibrosis · principal investigator
- N/ANCT03227094 · Simplification of CF-related Diabetes Screening at HomeInstitut de Recherches Cliniques de Montreal · completed · Cystic Fibrosis, Cystic Fibrosis-related Diabetes · principal investigator
- Ph2NCT02855307 · Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- Ph2NCT02846857 · Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · withdrawn · Type 1 Diabetes · principal investigator
- Ph2NCT02846831 · Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- N/ANCT02810691 · The Effect of Soluble Fiber to Reduce Post-prandial Glycemic Excursion in Adults With Cystic FibrosisInstitut de Recherches Cliniques de Montreal · completed · Cystic Fibrosis-related Diabetes, Cystic Fibrosis · principal investigator
- N/ANCT02631265 · Insulin-based Strategies to Prevent Hypoglycemia During ExerciseInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- Ph2NCT02626936 · Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop OperationInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- Ph2NCT02490085 · Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults With Type 2 Diabetes Under Intensive Insulin TherapyInstitut de Recherches Cliniques de Montreal · completed · Type 2 Diabetes · principal investigator
- Ph2NCT02490098 · Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · withdrawn · Type 1 Diabetes · principal investigator
- Ph2NCT02488616 · Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · withdrawn · Type 1 Diabetes · principal investigator
- N/ANCT02485132 · Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of SulfonylureaInstitut de Recherches Cliniques de Montreal · terminated · Type 2 Diabetes · principal investigator
- Ph2NCT02416765 · Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- Ph2NCT02189694 · Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Children With Type 1 Diabetes in a Diabetes CampInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- Ph2NCT01966393 · Closed-loop Control of Glucose Levels (Artificial Pancreas) for 60 Hours in Adults With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- Ph2NCT01930097 · Closed-loop Control of Glucose Levels After Meal Intake in Adults With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- Ph2NCT01930110 · Closed-loop Control of Glucose Levels (Artificial Pancreas) During Exercise in Adults With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- Ph2NCT01905020 · Closed-loop Control of Overnight Glucose Levels in Adults and Adolescents With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- Ph2NCT01828125 · Efficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · withdrawn · Type 1 Diabetes · principal investigator
- Ph2NCT01754337 · Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults and Adolescents With Type 1 DiabetesInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
- Ph1/Ph2NCT01297946 · Closed-loop Control of Glucose Levels in the Context of Exercise in Adults With Type-1 DiabetesInstitut de Recherches Cliniques de Montreal · completed · Type 1 Diabetes · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:06 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and sensor-augmented pump therapy in outpatient settingsDP3DK106930 · NIDDK · CLINICAL RESEARCH INSTITUTE OF MONTREAL · fiscal years 2015 · $2,509,367 awarded in 2015Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:06 UTC. The ranking covers the 200 most relevant of 73 PubMed records, and a shared surname and initials can bring in a namesake. All 73 on PubMed
- 241 citationsRCR 6.8
- 200 citationsRCR 6.0
- Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.Lancet Diabetes Endocrinol · 2015171 citationsRCR 6.9
- Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralente-regular) insulin regimen.Diabetes Care · 1999130 citationsRCR 3.6
- 119 citationsRCR 4.7
- Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial.Diabetes Care · 2015110 citationsRCR 3.7
- Resistance training does not contribute to improving the metabolic profile after a 6-month weight loss program in overweight and obese postmenopausal women.J Clin Endocrinol Metab · 2009104 citationsRCR 3.4
- Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.Lancet Diabetes Endocrinol · 201596 citationsRCR 3.7
- Effect of acarbose on insulin sensitivity in elderly patients with diabetes.Diabetes Care · 200094 citationsRCR 2.5
- Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states.J Clin Endocrinol Metab · 200391 citationsRCR 2.5